Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Cytek Biosciences, Inc. (CTKB)

NMS · Medical Devices

$4.46+0.05 (+1.13%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$576.0M
P/E (TTM)
EPS
$-0.59
Div Yield
52W Range
$3.28–$6.18
Beta
1.17

Company overview

Next earnings: 2026-08-05(8d)

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Peers in Medical Devices

All in industry →

Recent press releases

Cytek Biosciences, Inc. has not issued a press release in this window.

SEC filings

All filings →

Cytek Biosciences, Inc. has not filed an SEC document in this window.

Cytek Biosciences, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
33,497 sh-52.5%
17,173,028 sh+3.8%
5,008,309 sh+13369.4%
7,475,477 sh+7.8%
7,442,466 sh+7.2%
4,752,447 sh+39.0%
6,657,030 sh0.0%
4,146,964 sh+1.5%

People at Cytek Biosciences, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$8.9M
NI
06/25
$23.8M
NI
09/25
$52.3M
NI
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.00
Prior: $0.00
Revenue sparkline